CSI Market
Sign In | Register

Silo Pharma Inc (SILO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SILO quarterly Cash Flow →
Observing cash flow movements over recent quarters helps explain how Silo Pharma Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-4.23
Depreciation & amortization0.00
Amortization of Other Assets0.01
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.04
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets-0.04
Share-based Compensation0.95
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Allocated Stockbased Compensation-
Loss From Debt Extinguishment-
Increase Decrease In Inventory Current-
Amortization Of Prepaid Stockbased Expense-
Net Unrealized Loss On Equity Investments-
Gains Losses On Restructuring Of Debt-
Equity Shares Earned For Services-
Net Realized Loss On Shortterm Investments0.00
Bad Debt Expense Discontinued Operations-
Crypto Asset Unrealized Gain Loss Nonoperating-0.07
Amortization Of Prepaid Stockbased Professional Fees-
Common Stock Issued For Research And Development-
Income taxes1.13
Unrealized Gain (Loss) on Investments0.00
Increase (Decrease) in Receivables0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.99
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.12
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-4.66
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Payments to Acquire Short-term Investments1.22
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Equity Investment-
Collection On Note Receivable-
Payment For Acquisition Crypto Asset-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.64
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.36
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock3.73
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment For Direct Offering Costs In Cash-
Common Stock Redemption Amount-
Repayment Of Insurance Finance Loan-
Advance From A Related Party-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.86
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.66
Total Cash Flow0.84
4 historic quarters locked

Sign in to unlock the full Silo Pharma Inc cash flow history.

Sign In Create Free Account

About Silo Pharma Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-035576

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License